Personal information

No personal information available

Activities

Collapse all

Works (36)

Reply to Sujoy Khan

Pediatric Allergy and Immunology
2024-08 | Journal article
DOI: 10.1111/pai.14222
Contributors: Lisa P. van der Rijst; Karin M. de Winter‐de Groot; Marjolein S. de Bruin‐Weller; Marlies de Graaf
Source: check_circle
Crossref

The pleiotropic role of interleukin-13 in the pathogenesis of atopic dermatitis

British Journal of Dermatology
2024-08-14 | Journal article
DOI: 10.1093/bjd/ljae174
Contributors: Coco Dekkers; Marjolein de Bruin-Weller
Source: check_circle
Crossref

Aggregate Response Benefit in Skin Clearance and Itch Reduction With Upadacitinib or Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis®

Dermatitis®
2024-06-01 | Journal article
DOI: 10.1089/derm.2023.0153
Contributors: Jonathan I. Silverberg; Marjolein de Bruin-Weller; Brian M. Calimlim; Xiaofei Hu; Sarah A. Ofori; Andrew M. Platt; Henrique D. Teixeira; Kilian Eyerich; Jacob P. Thyssen
Source: check_circle
Crossref

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)

Dermatology and Therapy
2024-05 | Journal article
DOI: 10.1007/s13555-024-01157-5
Contributors: Eric L. Simpson; Vimal H. Prajapati; Yael A. Leshem; Raj Chovatiya; Marjolein S. de Bruin-Weller; Sonja Ständer; Andrew E. Pink; Brian M. Calimlim; Wan-Ju Lee; Henrique Teixeira et al.
Source: check_circle
Crossref

Single Cell Sequencing of Human Langerhans Cells Identifies Altered Gene Expression Profiles in Patients with Atopic Dermatitis

2024-05-09 | Preprint
DOI: 10.1101/2024.05.06.24306801
Contributors: Sara M. Tamminga; M. Marlot van der Wal; Elise S. Saager; Lian F. van der Gang; Celeste M. Boesjes; Astrid Hendriks; Yvonne Pannekoek; Marjolein S. de Bruin; Femke van Wijk; Nina M. van Sorge
Source: check_circle
Crossref

Dupilumab in daily practice for the treatment of Pediatric Atopic Dermatitis: 16-week clinical and biomarker results from the BioDay registry

2024-01-31 | Preprint
DOI: 10.22541/au.170670692.25578347/v1
Contributors: Esmé Kamphuis; Celeste M. Boesjes; Laura Loman; Daphne Bakker; Mila Poelhekken; Nicolaas Zuithoff; Marijke Kamsteeg; Geertruida Romeijn; Femke van Wijk; Marjolein de Bruin-Weller et al.
Source: check_circle
Crossref

IgE levels in patients with atopic dermatitis steadily decrease during treatment with dupilumab regardless of dose interval

Clinical & Experimental Allergy
2023-11 | Journal article
DOI: 10.1111/cea.14384
Contributors: Coco Dekkers; M. Marlot van der Wal; Leonie van den Noort; Daphne S. Bakker; Marjolein de Bruin‐Weller; Femke van Wijk
Source: check_circle
Crossref

Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab

Journal of Investigative Dermatology
2023-09 | Journal article
DOI: 10.1016/j.jid.2023.03.1659
Contributors: Coco Dekkers; M. Marlot van der Wal; Mohsin El Amrani; Matthijs van Luin; Daphne S. Bakker; Marjolein de Bruin-Weller; Femke van Wijk
Source: check_circle
Crossref

Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis

Allergy
2023-08 | Journal article
DOI: 10.1111/all.15717
Contributors: Roselie Achten; Judith Thijs; Marlot van der Wal; Chantal van Luijk; Marlies de Graaf; Daphne Bakker; Joke de Boer; Femke van Wijk; Marjolein de Bruin‐Weller
Source: check_circle
Crossref

Dupilumab has a profound effect on specific‐IgE levels of several food allergens in atopic dermatitis patients

Allergy
2023-03 | Journal article
DOI: 10.1111/all.15591
Contributors: Lotte S. Spekhorst; Lisa P. van der Rijst; Marlies de Graaf; Maxime van Megen; Nicolaas P. A. Zuithoff; André C. Knulst; Marjolein S. de Bruin‐Weller; Thuy‐My Le
Source: check_circle
Crossref

Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐severe atopic dermatitis patients

Clinical & Experimental Allergy
2023-02 | Journal article
DOI: 10.1111/cea.14269
Contributors: Roselie Achten; Judith Thijs; Chantal van Luijk; Edward Knol; Eveline Delemarre; Marlies de Graaf; Daphne Bakker; Joke de Boer; Femke van Wijk; Marjolein de Bruin‐Weller
Source: check_circle
Crossref

Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry

Acta Dermato-Venereologica
2023-02-16 | Journal article
DOI: 10.2340/actadv.v103.5243
Contributors: Celeste M. Boesjes; Liana F. Van der Gang; Nicolaas P.A. Zuithoff; Daphne S. Bakker; Lotte S. Spekhorst; Inge Haeck; Marijke Kamsteeg; Marlies De Graaf; Marjolein S. De Bruin-Weller
Source: check_circle
Crossref

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry

Pediatric Allergy and Immunology
2022-12 | Journal article
DOI: 10.1111/pai.13887
Contributors: Esmé Kamphuis; Celeste M. Boesjes; Laura Loman; Daphne S. Bakker; Mila Poelhekken; Nicolaas P. A. Zuithoff; Marijke Kamsteeg; Geertruida L. E. Romeijn; Femke van Wijk; Marjolein S. de Bruin‐Weller et al.
Source: check_circle
Crossref

Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

British Journal of Dermatology
2022-12-01 | Journal article
DOI: 10.1111/bjd.21867
Contributors: Eric L. Simpson; Joseph F. Merola; Jonathan I. Silverberg; Kristian Reich; Richard B. Warren; Delphine Staumont-Sallé; Giampiero Girolomoni; Kim Papp; Marjolein de Bruin-Weller; Jacob P. Thyssen et al.
Source: check_circle
Crossref

Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registry

JEADV Clinical Practice
2022-09 | Journal article
DOI: 10.1002/jvc2.35
Contributors: Lara S. van der Schoot; Hans J. M. M. Groenewoud; Marleen M. H. J. van Gelder; Marisol E. Otero; W. Peter Arnold; Maartje A. M. Berends; Marjolein S. De Bruin‐Weller; Sharon R. P. Dodemont; Marloes M. Kleinpenning; Marjolein I. A. Koetsier et al.
Source: check_circle
Crossref

The long‐term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis—52 week results from the Dutch BioDay Registry

Contact Dermatitis
2022-08 | Journal article
DOI: 10.1111/cod.14104
Contributors: Angelique N. Voorberg; Geertruida L. E. Romeijn; Marjolein S. de Bruin‐Weller; Marie L. A. Schuttelaar
Source: check_circle
Crossref

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab – a cross-sectional study from the BioDay registry

Journal of Dermatological Treatment
2022-05-19 | Journal article
DOI: 10.1080/09546634.2021.1937485
Contributors: Jart A. F. Oosterhaven; Lotte S. Spekhorst; Junfen Zhang; Angelique N. Voorberg; Geertruida L. E. Romeijn; Celeste M. Boesjes; Marlies de Graaf; Marjolein S. de Bruin-Weller; Marie L. A. Schuttelaar
Source: check_circle
Crossref

Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials

British Journal of Dermatology
2022-03 | Journal article
DOI: 10.1111/bjd.20810
Contributors: A. Wollenberg; L.A. Beck; M. de Bruin Weller; E.L. Simpson; S. Imafuku; M. Boguniewicz; R. Zachariae; C.K. Olsen; J.P. Thyssen
Source: check_circle
Crossref

Conjunctival inflammation in dupilumab‐treated atopic dermatitis comprises a multicellular infiltrate with elevated T1/T17 cytokines: A case series study

Allergy
2021-12 | Journal article
DOI: 10.1111/all.15064
Contributors: Daphne S. Bakker; José J. M. ter Linde; Mojtaba M. Amini; Lieneke F. M. Ariëns; Chantal M. van Luijk; Marjolein S. de Bruin‐Weller; Judith L. Thijs; Yvonne Vercoulen; Femke van Wijk
Source: check_circle
Crossref

Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis

Dermatology and Therapy
2021-12 | Journal article
DOI: 10.1007/s13555-021-00630-9
Contributors: Gil Yosipovitch; Marjolein de Bruin-Weller; April Armstrong; Jashin J. Wu; Pedro Herranz; Diamant Thaçi; Dimittri Delevry; Gaëlle Bégo-Le Bagousse; Raymond Zhang; Brad Shumel et al.
Source: check_circle
Crossref

Efficacy of Dupilumab in Atopic Dermatitis: The Patient’s Perspective

Dermatology and Therapy
2021-12 | Journal article
DOI: 10.1007/s13555-021-00621-w
Contributors: Marjolein de Bruin-Weller; Joseph F. Merola; Chih-ho Hong; Esther Serra Baldrich; Karel Ettler; Debra Sierka; Dimittri Delevry; Zhen Chen; Ana B. Rossi
Source: check_circle
Crossref

Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis

Journal of Investigative Dermatology
2021-08 | Journal article
DOI: 10.1016/j.jid.2021.01.022
Contributors: Daphne S. Bakker; Maria M. van der Wal; Lukas E.M. Heeb; Barbara Giovannone; Mindy Asamoah; Eveline M. Delemarre; Julia Drylewicz; Stefan Nierkens; Onur Boyman; Marjolein S. de Bruin-Weller et al.
Source: check_circle
Crossref

Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials

Dermatology and Therapy
2021-08-18 | Journal article
DOI: 10.1007/s13555-021-00558-0
Contributors: Christopher Griffiths; Marjolein de Bruin-Weller; Mette Deleuran; Maria Concetta Fargnoli; Delphine Staumont-Sallé; Chih-ho Hong; Jose Sánchez-Carazo; Peter Foley; Seong Jun Seo; Jérôme Msihid et al.
Source: check_circle
Crossref

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study

Journal of Dermatological Treatment
2021-02-17 | Journal article
DOI: 10.1080/09546634.2020.1866741
Contributors: Marjolein de Bruin-Weller; Andrew E. Pink; Annalisa Patrizi; Ana M. Gimenez-Arnau; Tove Agner; Pierre-Paul Roquet-Gravy; Silvia M. Ferrucci; Petr Arenberger; Ake Svensson; Marie L.A Schuttelaar et al.
Source: check_circle
Crossref

EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers

Allergy
2020-12 | Journal article
DOI: 10.1111/all.14492
Contributors: Daphne S. Bakker; Lieneke F. M. Ariens; Barbara Giovannone; DirkJan Hijnen; Eveline M. Delemarre; Edward Knol; Stefan Nierkens; Marjolein S. de Bruin‐Weller; Judith L. Thijs; Julia Drylewicz
Source: check_circle
Crossref

Systemic treatment in atopic dermatitis after 2018: from experienced‐based treatment to evidence‐based treatment?

British Journal of Dermatology
2020-12 | Journal article
DOI: 10.1111/bjd.19227
Contributors: M. Bruin‐Weller
Source: check_circle
Crossref

Biomarkers detected in dried blood spots from atopic dermatitis patients strongly correlate with disease severity

Allergy
2019-11 | Journal article
DOI: 10.1111/all.13839
Contributors: Judith L. Thijs; Renée Fiechter; Barbara Giovannone; Marjolein S. de Bruin‐Weller; Edward F. Knol; Carla A. F. M. Bruijnzeel‐Koomen; Julia Drylewicz; Stefan Nierkens; DirkJan Hijnen
Source: check_circle
Crossref

Conjunctivitis in dupilumab clinical trials

British Journal of Dermatology
2019-09 | Journal article
DOI: 10.1111/bjd.17869
Contributors: B. Akinlade; E. Guttman‐Yassky; M. Bruin‐Weller; E.L. Simpson; A. Blauvelt; M.J. Cork; E. Prens; P. Asbell; E. Akpek; J. Corren et al.
Source: check_circle
Crossref

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study

The Journal of Dermatology
2019-08 | Journal article
DOI: 10.1111/1346-8138.14982
Contributors: Jart A.F. Oosterhaven; Angelique N. Voorberg; Geertruida L.E. Romeijn; Marjolein S. de Bruin‐Weller; Marie L.A. Schuttelaar
Source: check_circle
Crossref

Time to get rid of the Investigator's Global Assessment as the primary outcome for clinical trials in atopic dermatitis?

British Journal of Dermatology
2019-07 | Journal article
DOI: 10.1111/bjd.18037
Contributors: M. Bruin‐Weller
Source: check_circle
Crossref

Infections in Dupilumab Clinical Trials in Atopic Dermatitis: A Comprehensive Pooled Analysis

American Journal of Clinical Dermatology
2019-06 | Journal article
DOI: 10.1007/s40257-019-00445-7
Contributors: Lawrence F. Eichenfield; Thomas Bieber; Lisa A. Beck; Eric L. Simpson; Diamant Thaçi; Marjolein de Bruin-Weller; Mette Deleuran; Jonathan I. Silverberg; Carlos Ferrandiz; Regina Fölster-Holst et al.
Source: check_circle
Crossref

EASI p‐EASI: Predicting disease severity in atopic dermatitis patients treated with cyclosporin A

Allergy
2019-03 | Journal article
DOI: 10.1111/all.13651
Contributors: Judith L. Thijs; Julia Drylewicz; Carla A. F. M. Bruijnzeel‐Koomen; Barbara Giovannone; Edward F. Knol; Marjolein S. de Bruin‐Weller; Stefan Nierkens; DirkJan Hijnen
Source: check_circle
Crossref

Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?: reply from the authors

British Journal of Dermatology
2018-05 | Journal article
DOI: 10.1111/bjd.16348
Contributors: M. de Bruin-Weller; N.M.H. Graham; G. Pirozzi; B. Shumel
Source: check_circle
Crossref

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

British Journal of Dermatology
2018-05 | Journal article
DOI: 10.1111/bjd.16156
Contributors: M. de Bruin-Weller; D. Thaçi; C.H. Smith; K. Reich; M.J. Cork; A. Radin; Q. Zhang; B. Akinlade; A. Gadkari; L. Eckert et al.
Source: check_circle
Crossref

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

British Journal of Dermatology
2018-03 | Journal article
DOI: 10.1111/bjd.15928
Contributors: A.M. Drucker; K. Eyerich; M.S. de Bruin-Weller; J.P. Thyssen; P.I. Spuls; A.D. Irvine; G. Girolomoni; S. Dhar; C. Flohr; D.F. Murrell et al.
Source: check_circle
Crossref

Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology

Journal of Medical Internet Research
2017-09-05 | Journal article
DOI: 10.2196/jmir.7512
Contributors: Lieneke FM Ariens; Florine ML Schussler-Raymakers; Cynthia Frima; Annebeth Flinterman; Eefje Hamminga; Bernd WM Arents; Carla AFM Bruijnzeel-Koomen; Marjolein S de Bruin-Weller; Harmieke van Os-Medendorp
Source: check_circle
Crossref

Peer review (8 reviews for 3 publications/grants)

Review activity for American journal of clinical dermatology. (5)
Review activity for Journal of allergy and clinical Immunology. (2)
Review activity for The lancet. (1)
How many people are using ORCID?